These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22015434)

  • 1. Effects of fluoxetine treatment on striatal dopamine transporter binding and cerebrospinal fluid insulin-like growth factor-1 in children with autism.
    Makkonen I; Kokki H; Kuikka J; Turpeinen U; Riikonen R
    Neuropediatrics; 2011 Oct; 42(5):207-9. PubMed ID: 22015434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
    Shang Y; Gibbs MA; Marek GJ; Stiger T; Burstein AH; Marek K; Seibyl JP; Rogers JF
    J Clin Psychopharmacol; 2007 Feb; 27(1):71-5. PubMed ID: 17224717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and dopamine transporter binding in children with autism determined by SPECT.
    Makkonen I; Riikonen R; Kokki H; Airaksinen MM; Kuikka JT
    Dev Med Child Neurol; 2008 Aug; 50(8):593-7. PubMed ID: 18754896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.
    Booij J; de Jong J; de Bruin K; Knol R; de Win MM; van Eck-Smit BL
    J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study.
    Lehto SM; Tolmunen T; Kuikka J; Valkonen-Korhonen M; Joensuu M; Saarinen PI; Vanninen R; Ahola P; Tiihonen J; Lehtonen J
    Neurosci Lett; 2008 Aug; 441(3):291-5. PubMed ID: 18588943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism.
    Riikonen R; Makkonen I; Vanhala R; Turpeinen U; Kuikka J; Kokki H
    Dev Med Child Neurol; 2006 Sep; 48(9):751-5. PubMed ID: 16904022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of dopamine transporter imaging on the brain of children with autism].
    Sun X; Yue J; Zheng C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):327-30. PubMed ID: 18610616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA, glutamate, dopamine and serotonin transporters expression on forgetting.
    Tellez R; Gómez-Viquez L; Liy-Salmeron G; Meneses A
    Neurobiol Learn Mem; 2012 Jul; 98(1):66-77. PubMed ID: 22633984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia.
    Tellez R; Gómez-Víquez L; Meneses A
    Neurobiol Learn Mem; 2012 Feb; 97(2):189-201. PubMed ID: 22183017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
    Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
    J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors.
    Kim CH; Cheon KA; Koo MS; Ryu YH; Lee JD; Chang JW; Lee HS
    Neuropsychobiology; 2007; 55(3-4):156-62. PubMed ID: 17657168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism.
    Vanhala R; Turpeinen U; Riikonen R
    Dev Med Child Neurol; 2001 Sep; 43(9):614-6. PubMed ID: 11570630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1.
    Hoexter MQ; Fadel G; Felício AC; Calzavara MB; Batista IR; Reis MA; Shih MC; Pitman RK; Andreoli SB; Mello MF; Mari JJ; Bressan RA
    Psychopharmacology (Berl); 2012 Nov; 224(2):337-45. PubMed ID: 22700036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal presynaptic dopaminergic dysfunction in gambling disorder: A
    Pettorruso M; Martinotti G; Cocciolillo F; De Risio L; Cinquino A; Di Nicola M; Camardese G; Migliara G; Moccia L; Conte E; Janiri L; Di Giuda D
    Addict Biol; 2019 Sep; 24(5):1077-1086. PubMed ID: 30226290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and autoradiographic evaluation of [(18)F]FE@CIT: a Comparison with [(123)I]beta-CIT and [(123)I]FP-CIT.
    Ettlinger DE; Häusler D; Wadsak W; Girschele F; Sindelar KM; Mien LK; Ungersböck J; Viernstein H; Kletter K; Dudczak R; Mitterhauser M
    Nucl Med Biol; 2008 May; 35(4):475-9. PubMed ID: 18482685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle.
    Best SE; Sarrel PM; Malison RT; Laruelle M; Zoghbi SS; Baldwin RM; Seibyl JP; Innis RB; van Dyck CH
    Psychopharmacology (Berl); 2005 Dec; 183(2):181-9. PubMed ID: 16175405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential alterations of dopamine transporter in the striatum and midbrain in patients with parkinsonian syndrome.
    Matesan MC; Cross DJ; Lewis DH; Minoshima S
    Clin Nucl Med; 2015 Mar; 40(3):191-4. PubMed ID: 25546191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.